Stay updated on BeGeRN Clinical Trial
Sign up to get notified when there's something new on the BeGeRN Clinical Trial page.

Latest updates to the BeGeRN Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoChange DetectedDifference0.6%
- Check23 days agoChange DetectedThe web page has been updated to reflect a new clinical trial focusing on the safety and efficacy of a combination treatment for diffuse large B-cell lymphoma, specifically highlighting the drugs Gemcitabine and Nivolumab, while removing previous details about a different treatment regimen.SummaryDifference23%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check45 days agoChange DetectedDifference0.3%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to BeGeRN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BeGeRN Clinical Trial page.